[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

AU2001295999A1 - Nateglinide-containing preparations - Google Patents

Nateglinide-containing preparations

Info

Publication number
AU2001295999A1
AU2001295999A1 AU2001295999A AU9599901A AU2001295999A1 AU 2001295999 A1 AU2001295999 A1 AU 2001295999A1 AU 2001295999 A AU2001295999 A AU 2001295999A AU 9599901 A AU9599901 A AU 9599901A AU 2001295999 A1 AU2001295999 A1 AU 2001295999A1
Authority
AU
Australia
Prior art keywords
nateglinide
containing preparations
antidiabetic
immediate
amorphous
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001295999A
Inventor
Chisato Makino
Nobutaka Ninomiya
Akira Yabuki
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ajinomoto Co Inc
Original Assignee
Ajinomoto Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ajinomoto Co Inc filed Critical Ajinomoto Co Inc
Publication of AU2001295999A1 publication Critical patent/AU2001295999A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

The present invention discloses, as a immediate-release preparation useful as an antidiabetic, a nateglinide-containing preparation comprising nateglinide as an active ingredient wherein the nateglinide is amorphous. <IMAGE>
AU2001295999A 2000-10-24 2001-10-23 Nateglinide-containing preparations Abandoned AU2001295999A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2000324373 2000-10-24
JP2000-324373 2000-10-24
PCT/JP2001/009291 WO2002034254A1 (en) 2000-10-24 2001-10-23 Nateglinide-containing preparations

Publications (1)

Publication Number Publication Date
AU2001295999A1 true AU2001295999A1 (en) 2002-05-06

Family

ID=18801918

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001295999A Abandoned AU2001295999A1 (en) 2000-10-24 2001-10-23 Nateglinide-containing preparations

Country Status (17)

Country Link
US (2) US7605180B2 (en)
EP (1) EP1334720B1 (en)
JP (3) JP4501054B2 (en)
KR (1) KR100869039B1 (en)
CN (1) CN100352432C (en)
AT (1) ATE406885T1 (en)
AU (1) AU2001295999A1 (en)
BR (1) BR0114896A (en)
CA (1) CA2426263C (en)
DE (1) DE60135674D1 (en)
DK (1) DK1334720T3 (en)
ES (1) ES2307653T3 (en)
MX (1) MXPA03003685A (en)
PT (1) PT1334720E (en)
RU (1) RU2271805C2 (en)
TW (1) TWI283573B (en)
WO (1) WO2002034254A1 (en)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SK9292002A3 (en) * 1999-12-28 2002-10-08 Ajinomoto Kk Oral preparations for diabetes
RU2281764C2 (en) * 2000-03-17 2006-08-20 Адзиномото Ко., Инк. Medicinal agents for treatment of complications associated with diabetes mellitus and neuropathy and their using
DE60130575T2 (en) * 2000-10-18 2008-04-30 Ajinomoto Co., Inc. PROCESS FOR THE PREPARATION OF ACYLPHENYL ALANINES
RU2273629C2 (en) * 2000-10-18 2006-04-10 Адзиномото Ко., Инк. Methods for preparing nateglinide crystals
WO2002034254A1 (en) * 2000-10-24 2002-05-02 Ajinomoto Co.,Inc. Nateglinide-containing preparations
CA2426764C (en) * 2000-10-24 2010-04-20 Ajinomoto Co., Inc. Nateglinide-containing hydrophilic pharmaceutical preparation
CN100422143C (en) * 2000-10-24 2008-10-01 味之素株式会社 Process for producing b-form nateglinide crystal
JP4833464B2 (en) * 2001-11-28 2011-12-07 大正製薬株式会社 Method for producing poorly soluble drug-containing solid preparation
US6861553B2 (en) 2002-07-03 2005-03-01 Teva Pharmaceuticals Industries Ltd. Process for preparing nateglinide and intermediates thereof
US7358390B2 (en) 2002-07-18 2008-04-15 Teva Pharmaceutical Industries Ltd. Polymorphic forms of nateglinide
US7148376B2 (en) 2002-07-18 2006-12-12 Teva Pharmaceutical Industries Ltd. Polymorphic forms of nateglinide
US7534913B2 (en) 2002-07-18 2009-05-19 Teva Pharmaceutica Industries Ltd. Crystalline form of nateglinide
US7420084B2 (en) 2002-07-18 2008-09-02 Teva Pharmaceutical Industries Ltd. Polymorphic forms of nateglinide
JP4505859B2 (en) * 2003-08-08 2010-07-21 味の素株式会社 Nateglinide-containing preparation
WO2005020979A1 (en) * 2003-09-03 2005-03-10 Ranbaxy Laboratories Limited A process for the preparation of pharmaceutical compositions of nateglinide
US20070219250A1 (en) * 2003-11-28 2007-09-20 Romi Singh Pharmaceutical Compositions of Nateglinide
WO2005094812A1 (en) * 2004-04-01 2005-10-13 Ajinomoto Co., Inc. Nateglinide-containing preparation
JP5551852B2 (en) * 2004-08-10 2014-07-16 味の素株式会社 Nateglinide-containing preparation with reduced bitterness
JP4974057B2 (en) * 2005-01-31 2012-07-11 味の素株式会社 A pharmaceutical composition for improving or treating impaired glucose tolerance, borderline diabetes, insulin resistance and hyperinsulinemia, comprising a hypoglycemic agent
DE102005047561A1 (en) * 2005-10-04 2007-04-05 Bayer Healthcare Ag Drug delivery system, useful to treat and/or prevent e.g. thromboembolic disease, comprises 5-chloro-N-(((5S)-2-oxo-3-(4-(3-oxo-4-morpholinyl)-phenyl)-1,3-oxazolidine-5-yl)-methyl)-2-thiophene carboxamide with fast release active substance
WO2008129846A1 (en) 2007-03-29 2008-10-30 Daiichi Sankyo Company, Limited Pharmaceutical composition
TR200801178A2 (en) * 2008-02-22 2009-09-23 Bi̇li̇m İlaç Sanayi̇ Ti̇caret A.Ş. Oral tablet compositions containing nateglinide and surfactant-ph regulating system
CN101590063A (en) * 2008-05-26 2009-12-02 中国科学院上海生命科学研究院 The application of tanshinone in the medicine of preparation treatment obesity and insulin resistant
BR112012023654B1 (en) 2010-03-19 2022-04-12 Daiichi Sankyo Company, Limited Method for producing granules containing anticoagulant agent and method for producing a pharmaceutical composition containing said agent
AU2011266820A1 (en) 2010-06-14 2013-01-24 Cipla Limited A process for the preparation of nateglinide
JPWO2013022059A1 (en) 2011-08-10 2015-03-05 第一三共株式会社 Pharmaceutical composition containing diamine derivative
CN102813636B (en) * 2012-08-28 2014-04-16 西南药业股份有限公司 Nateglinide tablet and its preparation method
CN105555258A (en) * 2013-07-22 2016-05-04 桑多斯股份公司 Formulations containing amorphous dapagliflozin
CA2987867C (en) 2015-06-09 2023-06-27 Capsugel Belgium Nv Formulations to achieve rapid dissolution of drug from spray-dried dispersions in capsules
JP6647902B2 (en) * 2015-10-30 2020-02-14 株式会社ファンケル Sustained release granules
KR20240025990A (en) * 2022-08-19 2024-02-27 주식회사 스카이테라퓨틱스 Amorphous sunitinib, preparation method thereof, and pharmaceutical composition containing amorphous sunitinib

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS56110612A (en) * 1980-02-08 1981-09-01 Yamanouchi Pharmaceut Co Ltd Readily disintegrable and absorbable compression molded article of slightly soluble drug
FR2525108B1 (en) * 1982-04-19 1989-05-12 Elan Corp Ltd HIGH-SOLUBILITY MEDICINES AND PROCESS FOR OBTAINING THEM
JPH0249720A (en) * 1988-05-18 1990-02-20 Mitsubishi Kasei Corp Slightly soluble drug composition
US5041232A (en) * 1990-03-16 1991-08-20 Lever Brothers Company, Division Of Conopco, Inc. Sulfonimines as bleach catalysts
JPH0415221A (en) 1990-05-08 1992-01-20 Daicel Chem Ind Ltd Preparation of polycarbonate
US5463116A (en) * 1991-07-30 1995-10-31 Ajinomoto Co., Inc. Crystals of N- (trans-4-isopropylcyclohexlycarbonyl)-D-phenylalanine and methods for preparing them
ES2100291T3 (en) * 1991-07-30 1997-06-16 Ajinomoto Kk CRYSTALS OF N- (TRANS-4-ISOPROPILCICLOHEXILCARBONIL) -D-PHENYLALANINE AND METHODS TO PREPARE THEM.
PT965339E (en) * 1996-11-15 2006-06-30 Ajinomoto Kk COMPOSITION OF NATEGLINIDE IN TABLETS
TW486370B (en) * 1996-12-25 2002-05-11 Yamanouchi Pharma Co Ltd Rapidly disintegrable pharmaceutical composition
KR100610403B1 (en) * 1998-01-20 2006-08-10 어플라이드 애널리티컬 인더스트리즈, 인크. A pharmaceutical composition comprising a liquid or semi-solid composition and a process for preparing the same
US6559188B1 (en) * 1999-09-17 2003-05-06 Novartis Ag Method of treating metabolic disorders especially diabetes, or a disease or condition associated with diabetes
SK9292002A3 (en) * 1999-12-28 2002-10-08 Ajinomoto Kk Oral preparations for diabetes
RU2281764C2 (en) * 2000-03-17 2006-08-20 Адзиномото Ко., Инк. Medicinal agents for treatment of complications associated with diabetes mellitus and neuropathy and their using
RU2273629C2 (en) * 2000-10-18 2006-04-10 Адзиномото Ко., Инк. Methods for preparing nateglinide crystals
DE60130575T2 (en) * 2000-10-18 2008-04-30 Ajinomoto Co., Inc. PROCESS FOR THE PREPARATION OF ACYLPHENYL ALANINES
CN100422143C (en) * 2000-10-24 2008-10-01 味之素株式会社 Process for producing b-form nateglinide crystal
WO2002034254A1 (en) * 2000-10-24 2002-05-02 Ajinomoto Co.,Inc. Nateglinide-containing preparations
CA2426764C (en) * 2000-10-24 2010-04-20 Ajinomoto Co., Inc. Nateglinide-containing hydrophilic pharmaceutical preparation
US6830759B2 (en) * 2002-06-28 2004-12-14 Ajinomoto Co., Inc. Antidiabetic preparation for oral administration
JP4505859B2 (en) * 2003-08-08 2010-07-21 味の素株式会社 Nateglinide-containing preparation

Also Published As

Publication number Publication date
EP1334720A4 (en) 2004-02-04
EP1334720A1 (en) 2003-08-13
DE60135674D1 (en) 2008-10-16
EP1334720B1 (en) 2008-09-03
CA2426263A1 (en) 2003-04-23
CN100352432C (en) 2007-12-05
JP2013028636A (en) 2013-02-07
KR20030042027A (en) 2003-05-27
JP2010100654A (en) 2010-05-06
US20040014815A1 (en) 2004-01-22
US20090203791A1 (en) 2009-08-13
WO2002034254A1 (en) 2002-05-02
US7605180B2 (en) 2009-10-20
JP5610165B2 (en) 2014-10-22
CA2426263C (en) 2010-05-25
KR100869039B1 (en) 2008-11-17
CN1482903A (en) 2004-03-17
ATE406885T1 (en) 2008-09-15
TWI283573B (en) 2007-07-11
JP4501054B2 (en) 2010-07-14
BR0114896A (en) 2003-08-12
JPWO2002034254A1 (en) 2004-08-26
RU2271805C2 (en) 2006-03-20
PT1334720E (en) 2008-09-30
DK1334720T3 (en) 2009-01-19
MXPA03003685A (en) 2004-01-26
ES2307653T3 (en) 2008-12-01

Similar Documents

Publication Publication Date Title
AU2001295999A1 (en) Nateglinide-containing preparations
NZ527032A (en) Isoxazoline derivative and herbicide containing the same as the active ingredient
AU2002305578A1 (en) Applanation tonometer
AU2001279972A1 (en) Pesticidal formulations
AU2001262271A1 (en) Substituted iminoazines used as herbicides
AU2001230477A1 (en) Active aid for a handheld camera
AU2001269844A1 (en) Self-standing, hand held implements
USD469180S1 (en) Elongated applicator handle having a distributor at both ends
USD462616S1 (en) Bottle
AU2002225025A1 (en) Agrochemical formulations
USD456051S1 (en) Exercise device
USD488863S1 (en) Containers for components of medical devices
USD454308S1 (en) Bottle
USD451971S1 (en) Exercise device
EP1026162A4 (en) Antirheumatic
USD449424S1 (en) Horseshoe shaped novelty hat
USD457990S1 (en) Animal toy ring
AUPR836201A0 (en) Agricultural implements
USD447194S1 (en) Cookie-shaped toy
USD447415S1 (en) Trigger sprayer
USD444705S1 (en) Cap
AU2001262282A1 (en) 3-(4,5-dihydroisoxazole-5-yl)benzoylcyclohexenones and the use thereof as herbicides
AU2001289902A1 (en) Novel herbicides
USD470741S1 (en) Knob
AU2362401A (en) N-phenylcarbamates having a microbicide, insecticide and acaricide effect